461 related articles for article (PubMed ID: 28680754)
1. CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer.
Li J; Wang L; Chen X; Li L; Li Y; Ping Y; Huang L; Yue D; Zhang Z; Wang F; Li F; Yang L; Huang J; Yang S; Li H; Zhao X; Dong W; Yan Y; Zhao S; Huang B; Zhang B; Zhang Y
Oncoimmunology; 2017; 6(6):e1320011. PubMed ID: 28680754
[TBL] [Abstract][Full Text] [Related]
2. CD39/CD73 Dysregulation of Adenosine Metabolism Increases Decidual Natural Killer Cell Cytotoxicity: Implications in Unexplained Recurrent Spontaneous Abortion.
Zhu J; Song G; Zhou X; Han TL; Yu X; Chen H; Mansell T; Novakovic B; Baker PN; Cannon RD; Saffery R; Chen C; Zhang H
Front Immunol; 2022; 13():813218. PubMed ID: 35222389
[TBL] [Abstract][Full Text] [Related]
3. Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors.
Ryzhov SV; Pickup MW; Chytil A; Gorska AE; Zhang Q; Owens P; Feoktistov I; Moses HL; Novitskiy SV
J Immunol; 2014 Sep; 193(6):3155-64. PubMed ID: 25127858
[TBL] [Abstract][Full Text] [Related]
4. Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways.
Giatromanolaki A; Kouroupi M; Pouliliou S; Mitrakas A; Hasan F; Pappa A; Koukourakis MI
Life Sci; 2020 Oct; 259():118389. PubMed ID: 32898522
[TBL] [Abstract][Full Text] [Related]
5. Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages - a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape.
Montalbán Del Barrio I; Penski C; Schlahsa L; Stein RG; Diessner J; Wöckel A; Dietl J; Lutz MB; Mittelbronn M; Wischhusen J; Häusler SFM
J Immunother Cancer; 2016; 4():49. PubMed ID: 27532024
[TBL] [Abstract][Full Text] [Related]
6. STAT3 promotes differentiation of monocytes to MDSCs via CD39/CD73-adenosine signal pathway in oral squamous cell carcinoma.
Cui H; Lan Z; Zou KL; Zhao YY; Yu GT
Cancer Immunol Immunother; 2023 May; 72(5):1315-1326. PubMed ID: 36436019
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses.
Shevchenko I; Mathes A; Groth C; Karakhanova S; Müller V; Utikal J; Werner J; Bazhin AV; Umansky V
Oncoimmunology; 2020 Apr; 9(1):1744946. PubMed ID: 33457090
[TBL] [Abstract][Full Text] [Related]
8. Location of CD39
Koppensteiner L; Mathieson L; Pattle S; Dorward DA; O'Connor R; Akram AR
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37648263
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of CD39, CD73, HIF-1α, and their related miRNAs expression in decidua of preeclampsia cases compared to healthy pregnant women.
Yousefzadeh Y; Soltani-Zangbar MS; Kalafi L; Tarbiat A; Shahmohammadi Farid S; Aghebati-Maleki L; Parhizkar F; Danaii S; Taghavi S; Jadidi-Niaragh F; Samadi Kafil H; Mahmoodpoor A; Ahmadian Heris J; Hojjat-Farsangi M; Yousefi M
Mol Biol Rep; 2022 Nov; 49(11):10183-10193. PubMed ID: 36048381
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of CD39, CD73, and HIF-1 α expression besides their related miRNAs in PBMCs of women with recurrent pregnancy loss.
Parhizkar F; Kiani A; Darzi S; Motavalli R; Noori Dolama F; Yousefzadeh Y; Aghebati-Maleki L; Pia H; Abdollahi-Fard S; Mardi A; Danaii S; Ahmadian Heris J; Yousefi M; Soltani-Zangbar MS
J Reprod Immunol; 2023 Mar; 156():103820. PubMed ID: 36758470
[TBL] [Abstract][Full Text] [Related]
12. Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer.
Li L; Wang L; Li J; Fan Z; Yang L; Zhang Z; Zhang C; Yue D; Qin G; Zhang T; Li F; Chen X; Ping Y; Wang D; Gao Q; He Q; Huang L; Li H; Huang J; Zhao X; Xue W; Sun Z; Lu J; Yu JJ; Zhao J; Zhang B; Zhang Y
Cancer Res; 2018 Apr; 78(7):1779-1791. PubMed ID: 29374065
[TBL] [Abstract][Full Text] [Related]
13. 1α,25-dihydroxyvitamin D3 acts via transforming growth factor-β to up-regulate expression of immunosuppressive CD73 on human CD4+ Foxp3- T cells.
Mann EH; Chambers ES; Chen YH; Richards DF; Hawrylowicz CM
Immunology; 2015 Nov; 146(3):423-31. PubMed ID: 26251265
[TBL] [Abstract][Full Text] [Related]
14. Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia.
Synnestvedt K; Furuta GT; Comerford KM; Louis N; Karhausen J; Eltzschig HK; Hansen KR; Thompson LF; Colgan SP
J Clin Invest; 2002 Oct; 110(7):993-1002. PubMed ID: 12370277
[TBL] [Abstract][Full Text] [Related]
15. Protective role of hypoxia-inducible factor-1α-dependent CD39 and CD73 in fulminant acute liver failure.
Tak E; Jung DH; Kim SH; Park GC; Jun DY; Lee J; Jung BH; Kirchner VA; Hwang S; Song GW; Lee SG
Toxicol Appl Pharmacol; 2017 Jan; 314():72-81. PubMed ID: 27899277
[TBL] [Abstract][Full Text] [Related]
16. Monocytic myeloid-derived suppressor cells as a potent suppressor of tumor immunity in non-small cell lung cancer.
Pogoda K; Pyszniak M; Rybojad P; Tabarkiewicz J
Oncol Lett; 2016 Dec; 12(6):4785-4794. PubMed ID: 28101225
[TBL] [Abstract][Full Text] [Related]
17. CD73 expression in myeloid-derived suppressor cells is correlated with clinical stages in head and neck squamous cell carcinomas.
Zheng W; Zhu Y; Chen X; Zhao J
Ann Transl Med; 2021 Jul; 9(14):1148. PubMed ID: 34430589
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation in CD39/CD73 Axis May Trigger the Upsurge of the Immune Suppressive Agent Adenosine in OSA Patients.
Díaz-García E; García-Sánchez A; Alfaro E; López-Fernández C; Mañas E; Casitas R; Vega S; Cano-Pumarega I; García-Río F; Cubillos-Zapata C
Arch Bronconeumol; 2024 Apr; 60(4):207-214. PubMed ID: 38485582
[TBL] [Abstract][Full Text] [Related]
19. Ectonucleotidase-Mediated Suppression of Lupus Autoimmunity and Vascular Dysfunction.
Knight JS; Mazza LF; Yalavarthi S; Sule G; Ali RA; Hodgin JB; Kanthi Y; Pinsky DJ
Front Immunol; 2018; 9():1322. PubMed ID: 29942314
[TBL] [Abstract][Full Text] [Related]
20. Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73
Ahmadi P; Hartjen P; Kohsar M; Kummer S; Schmiedel S; Bockmann JH; Fathi A; Huber S; Haag F; Schulze Zur Wiesch J
Cells; 2020 Jul; 9(8):. PubMed ID: 32707842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
